Please login to the form below

Not currently logged in
Email:
Password:

Kantar Health

This page shows the latest Kantar Health news and features for those working in and with pharma, biotech and healthcare.

Health activators lack confidence in primary healthcare

Health activators lack confidence in primary healthcare

Based on findings from Kantar Health's National Health and Wellness Survey, the report explores how healthcare decision-makers - or 'health activators' - influence the care of their own and their families' ... providers. Kathy Annunziata, vice president

Latest news

  • Community research Community research

    This is especially relevant for sensitive health topics. As a rule, online research communities and forums are especially appropriate when:. ... vice president, integrated strategies and digital solutions, Kantar Health.

  • Depth perception: diabetes in India Depth perception: diabetes in India

    Unlike diabetes hot spots like China and the US – where risk factors are often hereditary – almost two-thirds of the Indian patients Kantar Health spoke to who had developed diabetes did ... The Author. Reena Thapar is a research manager at Kantar

  • First mover advantage: ASCO 2012 First mover advantage: ASCO 2012

    Kantar Health Oncology Market Access, Healthcare Reform, Spring 2012.). When considering an emerging market, the issue becomes that much more complex. ... Stephen Potts, Kantar Health).

  • Developing drugs to conquer cancer Developing drugs to conquer cancer

    On May 7, 2012, Gordon Gochenauer of Kantar Health wrote in a blog that perhaps 2012 could be designated as the 'Year of Many Cancers'. ... Highlights from ASCO 2012. Other key information that Kantar noted but did not blog on includes the following:.

  • NHS reforms increase need for pharma to engage with all stakeholders

    The discussion brought together Bayer Healthcare's Philip Ashman, Sue Kilby a leading UK payer, Kantar Health's Mark Sales and Sudler &Hennessey's Norbert Brunhuber, all of whom provided a ... The webinar was produced in association with Sudler &Hennessey

More from news
Approximately 2 fully matching, plus 20 partially matching documents found.

Latest Intelligence

  • The importance of real-world data to the pharma industry The importance of real-world data to the pharma industry

    Geneviève Bonnelye, MsC, Divisional President - Real World Evidence, Kantar Health. ... Andrew Miniuks, MBA, MA, Regional Account Director - Europe, Kantar Health.

  • Is obesity really a problem in Brazil? Is obesity really a problem in Brazil?

    According to Kantar Health's National Health and Wellness Survey (NHWS), 34% of Brazilian adults (18+ years) are overweight, and another 18% are obese. ... The study by Eisai and Kantar Health looked at the effect of obesity on work productivity by

  • Oncology drugs under AMNOG: part two Oncology drugs under AMNOG: part two

    Negotiation strategy and skill of the manufacturer and Germany's statutory health insurance the GKV. ... oncology market access – EU consultant, Kantar Health.

  • The digital transformation of market research The digital transformation of market research

    Click here to read the full article on Kantar Health's PMHub profile. ... vice president, integrated strategies &digital solutions, Kantar Health.

  • Oncology drugs under AMNOG: part one Oncology drugs under AMNOG: part one

    Usually the G-BA also seeks the advice of expert Health Technology Assessment (HTA) body IQWiG (the Institute for Quality and Efficiency in Healthcare), to determine the level of added benefit ... oncology market access – EU consultant, Kantar Health.

More from intelligence
Approximately 0 fully matching, plus 12 partially matching documents found.

Latest appointments

  • HRW bolsters global management team HRW bolsters global management team

    She has previously worked for Cello Health Insight and Kantar Group, where she served as survey management director.

  • Research Partnership appoints new directors Research Partnership appoints new directors

    Prior to this, Cunningham has also served at Cello Health Insight as its research director. ... Anderson joins the group from the Epsom, UK-based healthcare market research group Kantar Health, where he spent the last nine years working on large-scale

  • Kantar Health Europe appoints chief executive officer Kantar Health Europe appoints chief executive officer

    Kantar Health Europe appoints chief executive officer. Michel Murino takes on this newly created role. ... Kantar Health has promoted Michel Murino to the newly created role of chief executive officer for Kantar Health Europe.

  • Massimo Bufi joins Cello Health Insight Massimo Bufi joins Cello Health Insight

    Cello Health Insight has appointed Massimo Bufi as a senior methodologist at director level. ... Kantar Health, where she was a senior research analyst.

  • Kantar Health promotes Jade Cusick to chief client officer Kantar Health promotes Jade Cusick to chief client officer

    Healthcare consulting company Kantar Health has promoted Jade Cusick to chief client officer. ... Cusick joined Kantar Health in 2001 and was previously chief client officer of the firm's Americas business unit.

More from appointments
Approximately 7 fully matching, plus 11 partially matching documents found.

Latest from PMHub

  • Research Partnership announces several new appointments

    Prior to this she was Research Director at Cello Health Insight. ... Morten joins us from Kantar Health, where he has spent the last 9 years, with a particular emphasis on large-scale quantitative and brand tracking projects for international clients.

  • Duncan Munro joins Cello Health Insight as Joint Head of ‘IQ’ Practice

    Health Insight in 2012 from Kantar Health. ... Cello Health Insight’ s IQ practice is the quantitative arm of the business.

  • Using new technologies to capture the patient's voice

    While there is no one ‘ formula’ for becoming an online health activist, the common thread is that these patients have earned the authority to talk about their condition. ... The author. Brian Mondry, vice president, integrated strategies &digital

  • Oncology drugs under AMNOG

    Usually the G-BA also seeks the advice of expert Health Technology Assessment (HTA) body IQWiG (the Institute for Quality and Efficiency in Healthcare), to determine the level of added benefit ... Written by Christine Henry, oncology market access – EU

  • Kantar Health

    Kantar Health. Kantar Health is a leading global healthcare consulting firm and trusted advisor to many of the world’ s leading pharmaceutical, biotech, and medical device and diagnostic companies. ... brand and market leadership.Kantar Health deeply

More from PMHub
Approximately 2 fully matching, plus 3 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Hive

We're a healthcare communications agency that does things differently. We put patients at the heart of everything we do, while...

Latest intelligence

PM Society Digital Awards – the power of together
Our chief executive, Emma Statham, writes about the value of awards and the power of together....
Seduction_feature_image_thumb.jpg
Seduce anyone in four simple steps
You know the health of the global economy is dependent on our ability to seduce one another – don’t you? And you know that we need to be able to...
What Would Jeremy Do? : Assessing the impact of a Corbyn-led Labour government
GK Strategy are delighted to announce the launch our latest briefing paper entitled ‘What Would Jeremy Do? Assessing the impact of a Corbyn-led Labour government’....

Infographics